Waxaa soo raacaya Korea, Jarmalka, Ingiriiska, Japan, Mexico, New Zealand iyo Belgium oo ku kala baahsan Top 10.
Shirkadaha dhirta yaryar ee yaryar ayaa ah xeerka halkii laga reebayo, iyadoo boqolkiiba 72 shirkadaha biotechnology ee dalka Mareykanka haysta 50 ama ka yar shaqaale.
Qiimaynta Kharashka R-D ee Qaybta Biyootirnoolajiyada
Tirada shirkadaha waa hal dariiqo oo lagu barbar dhigi karo waddanka, halka kharashaadka cilmi baarista iyo horumarinta ay yihiin kuwo kale. Faransiiska, oo ah siddeed ilaa hal, ku dhawaad $ 27 bilyan wax yar oo ka badan $ 3 bilyan sannadka 2012. Kuwa kale ee qarashka badan waa Switzerland, Kuuriya, Japan, Jarmalka, iyo Danmark oo dhan hal bilyan oo doolar.
Nooca Isbedelka ee Cilmi-baarista iyo Horumarka
Hase yeeshee, miisaaniyadda cilmi-baarista iyo horumarinta ayaa dareemay hoos u dhac ku yimid Midowga Yurub, Japan, iyo Maraykanka tan iyo 2008-dii, iyada oo boqolkiiba 1,6 boqolkiiba korodhka sanadlaha ee celcelis ahaan laga soo bilaabo 2008 illaa 2012-kii. Dhanka kale, Shiinaha ayaa sii waday in ay kor u qaadaan kharashka R & D guud ahaan guud ahaan , iyada oo labanlaabmeysa inta u dhexeysa 2008 iyo 2012.
Natiijo ahaan, waxaa la filayaa in Shiinuhu uu noqon doono rukhsadda ugu weyn ee R & D sannadka 2019, sida laga soo xigtay OECD. Warbixinta 2012 ayaa lagu ogaaday in dhaqaalaha dadwaynaha uu wali ku adag yahay dalal badan, sidaa darteed ma awoodeen inay kor u qaadaan miisaaniyada R & D maalgelinta dowladdda sida lagu sameeyey dhererka dhibaatooyinka dhaqaale ee 2008-2010.
Si kastaba ha ahaatee, warbixinta OECD ee sayniska iyo tiknoolajiyadda, si kastaba ha ahaatee, waxay u muuqataa in sawirka warshadu uu si wanaagsan u eegay sannadihii dambe ee dhowr dalal oo aan ahayn OECD, oo ay ku jiraan Singapore, Brazil, China, Hindiya iyo Koonfur Afrika (OECD, 2010).
Inkasta oo Japan ay kaalinta labaad kaga jirto qiimeyno dhowr ah oo ay bixiso OECD, haddana kuma jirto darajada 5-aad ee ugu sareysa iyada oo la eegayo ilaha kale iyo shuruudaha. Bishii Agoosto 2010, Scientific Amercian ayaa ka mid ah wadamada ugu sareeya 5 dalxiis ee 'Worldview Scorecard' oo ah USA, Singapore, Canada, Sweden iyo Denmark.
Qiimeyntaas ayaa la sameeyay iyada oo la adeegsanayo shuruudaha soo socda: IP iyo awooda lagu ilaaliyo, xoojinta, oo lagu qeexay kharashka R & D, helitaanka raasamaal diineed iyo taageero, helitaanka shaqaale khabiir iyo guud ahaan waddanka marka la eego ganacsiga iyo aasaas kale. Wadamadu si fiican u shaqeynayaan waa kuwo leh dhiirigelin xoog leh oo horumarinta tiknoolajiyada iyo fursado badan oo lagu helo maalgalinta cilmi-baarista.
Warbixinta Global Biotechnology 2010, Ernst iyo Young, ayaa tilmaamaya in Shiinaha iyo Hindiya ay yihiin labada dal ee ugu sarreeya sidii loo kordhin lahaa waxsoosaarka guud ee gudaha (GDP) inta lagu gudajiray Dhibaatada Caalamka ee 2dii sano ee la soo dhaafay.
Shiinaha ayaa soo jeediyay in Shiinuhu uu dhawaan noqon doono kii saddexaad ee ugu sarreysa daawooyinka dawooyinka ka dib Maraykanka iyo Japan, iyo, inuu yahay meel caan ah oo aan qaali ahayn oo loogu talagalay inuu dibadda u soo baxo, wuxuu si fiican u qaban doonaa sanadaha soo socda. Hindiya ayaa sidoo kale ka faa'iideysatay hoos u dhigista iyo qarashka qarashka dalalka kale inta lagu jiro xiisadda dhaqaale, iyada oo ay ugu wacan tahay shaqaalaheeda xirfad sare leh iyo qiimaha wax soo saarka iyo kharashka cilmi-baarista.
Ilaha:
OECD, La sii daayay July 2015. http://www.oecd.org/sti/inno/keybiotechnologyindicators.htm
Ernst & Young, 2010. Beyond Xuduudaha: Warbixinta Global biotechnology 2010.